- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug-induced liver injury due to varenicline: a case report ; volume:12 ; number:1 ; day:8 ; month:6 ; year:2012 ; pages:1-5 ; date:12.2012
BMC gastroenterology ; 12, Heft 1 (8.6.2012), 1-5, 12.2012
- Urheber
-
Sprague, David
- Beteiligte Personen und Organisationen
-
Bambha, Kiran
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-12-65
- URN
-
urn:nbn:de:1111-201607157730
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sprague, David
- Bambha, Kiran
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug-induced liver injury due to tofacitinib: a case report
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
The challenge of drug-induced liver injury (DILI)
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
CD36 deficiency ameliorates drug-induced acute liver injury in mice
Rat precision-cut liver slices predict drug-induced cholestatic injury
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
New approaches to improve prediction of drug-induced liver injury
Drug-induced liver injury due to tofacitinib: a case report
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
The challenge of drug-induced liver injury (DILI)
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
CD36 deficiency ameliorates drug-induced acute liver injury in mice
Rat precision-cut liver slices predict drug-induced cholestatic injury
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
New approaches to improve prediction of drug-induced liver injury
Drug-induced liver injury due to tofacitinib: a case report
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
The challenge of drug-induced liver injury (DILI)
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
CD36 deficiency ameliorates drug-induced acute liver injury in mice
Rat precision-cut liver slices predict drug-induced cholestatic injury
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes